Diabetes and Cardiovascular Disease Booklet
The sixth booklet in a Ministry of Health series about the health targets has been released, focused on work happening in cardiovascular disease (CVD) and diabetes management.
diabetes
Suspension of Avandia (rosiglitazone) from New Zealand market
The medicine for diabetes called rosiglitazone is to be withdrawn from the NZ market from April 2011 following saftey review that has found increased risk of cardiovascular issues.